Her-2, Robert Bazell Paperback
We're sorry! This product is not available.
Description & Features+
Her-2, Robert Bazell Paperback. Provides a close-up look at Genentech's new cancer drug, Herceptin, a nontoxic therapy that deactivates the protein that makes breast cells turn malignant, and offers a detailed account of its creation, development, and promise as an effective treatment. 60,000 first printing. Tour.
From the Manufacturer +
Q & A+